Literature DB >> 26891864

Alkaptonuria: An example of a "fundamental disease"--A rare disease with important lessons for more common disorders.

James A Gallagher1, Jane P Dillon2, Nicolas Sireau3, Oliver Timmis4, Lakshminarayan R Ranganath5.   

Abstract

"Fundamental diseases" is a term introduced by the charity Findacure to describe rare genetic disorders that are gateways to understanding common conditions and human physiology. The concept that rare diseases have important lessons for biomedical science has been recognised by some of the great figures in the history of medical research, including Harvey, Bateson and Garrod. Here we describe some of the recently discovered lessons from the study of the iconic genetic disease alkaptonuria (AKU), which have shed new light on understanding the pathogenesis of osteoarthritis. In AKU, ochronotic pigment is deposited in cartilage when collagen fibrils become susceptible to attack by homogentisic acid (HGA). When HGA binds to collagen, cartilage matrix becomes stiffened, resulting in the aberrant transmission of loading to underlying subchondral bone. Aberrant loading leads to the formation of pathophysiological structures including trabecular excrescences and high density mineralised protrusions (HDMPs). These structures initially identified in AKU have subsequently been found in more common osteoarthritis and appear to play a role in joint destruction in both diseases.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alkaptonuria; Exposed collagen hypothesis; Fundamental disease; High density mineralised protrusions (HDMPs); Osteoarthritis; Rare disease; Trabecular excrescences

Mesh:

Year:  2016        PMID: 26891864     DOI: 10.1016/j.semcdb.2016.02.020

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  7 in total

1.  Phenylalanine Is a Novel Marker for Radiographic Knee Osteoarthritis Progression: The MOST Study.

Authors:  Guangju Zhai; Xianbang Sun; Edward W Randell; Ming Liu; Na Wang; Irina Tolstykh; Proton Rahman; James Torner; Cora E Lewis; Michael C Nevitt; Ali Guermazi; Frank Roemer; David T Felson
Journal:  J Rheumatol       Date:  2020-05-01       Impact factor: 4.666

2.  Reduced primary cilia length and altered Arl13b expression are associated with deregulated chondrocyte Hedgehog signaling in alkaptonuria.

Authors:  Stephen D Thorpe; Silvia Gambassi; Clare L Thompson; Charmilie Chandrakumar; Annalisa Santucci; Martin M Knight
Journal:  J Cell Physiol       Date:  2017-03-31       Impact factor: 6.384

3.  A robust bacterial assay for high-throughput screening of human 4-hydroxyphenylpyruvate dioxygenase inhibitors.

Authors:  Jessie Neuckermans; Alan Mertens; Dinja De Win; Ulrich Schwaneberg; Joery De Kock
Journal:  Sci Rep       Date:  2019-10-02       Impact factor: 4.379

Review 4.  Alkaptonuria: Current Perspectives.

Authors:  Andrea Zatkova; Lakshminarayan Ranganath; Ludevit Kadasi
Journal:  Appl Clin Genet       Date:  2020-01-23

5.  Adequacy of nitisinone for the management of alkaptonuria.

Authors:  Khawar Abbas; Jawad Basit; Mohammad Ebad Ur Rehman
Journal:  Ann Med Surg (Lond)       Date:  2022-08-07

6.  HGDiscovery: An online tool providing functional and phenotypic information on novel variants of homogentisate 1,2- dioxigenase.

Authors:  Malancha Karmakar; Vittoria Cicaloni; Carlos H M Rodrigues; Ottavia Spiga; Annalisa Santucci; David B Ascher
Journal:  Curr Res Struct Biol       Date:  2022-08-30

7.  Expression of tyrosine pathway enzymes in mice demonstrates that homogentisate 1,2-dioxygenase deficiency in the liver is responsible for homogentisic acid-derived ochronotic pigmentation.

Authors:  Peter J M Wilson; Lakshminarayan R Ranganath; George Bou-Gharios; James A Gallagher; Juliette H Hughes
Journal:  JIMD Rep       Date:  2020-11-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.